US medical giants say Australia’s Pharmaceutical Benefits Scheme is an “egregious and discriminatory” program that Trump ...

Staff and funding cuts to the NIH, FDA and USAID could have downstream implications for R&D in the pharma industry, experts ...

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...

Here is an excerpt from the article: “On February 20, Emily Field, Head of European Pharma Research at Barclays, appeared on CNBC to discuss the dynamics of the pharmaceutical sector ...

ANI Pharmaceuticals (NASDAQ:ANIP – Get Free Report)‘s stock had its “buy” rating reissued by HC Wainwright in a research ...

If Mölndal were shut down, it would spell the end for Sweden as a major player in global pharma research. The country has a large number of small biotech companies, and one or two speciality ...

Oklahoma State University is expanding its medical center in Tulsa – a move leaders say will have a positive ripple effect ...

Izuchukwu Okpalanwaka is a pharmacist and a doctoral researcher at the Texas Tech University Health Science Center (TTUHSC), United States. He is also the co-founder of the Tropical Medical Oncology ...

Discover why pharmaceutical-grade supplements command premium prices and whether their higher standards of purity, potency ...

American biggies are joining hands with Chinese companies. AbbVie signed a deal with Simcere Zaiming for a multiple myeloma ...

StockNews.com upgraded shares of Ligand Pharmaceuticals (NASDAQ:LGND – Free Report) from a sell rating to a hold rating in a ...

China’s growing influence on pharmaceutical research and development represents a significant wildcard for the industry in 2025. The country’s clinical trial landscape continues to expand ...